Latest

Nov 03, 2017
Pharmaceutical Executive
Agency leaders go slow in weighing changes to DTC ads and off-label marketing. Jill Wechsler reports.
Nov 01, 2017
Pharmaceutical Executive
This article explores the difficult nature of developing drugs for rare diseases and discusses what a pharmaceutical executive can actively do to help increase success.
Oct 31, 2017
Ed Gudaitis Allergan VP and Country Manager, Canada, explains how embracing disruption is his secret to success.
Oct 24, 2017
Pharmaceutical Executive
Navigating Data Privacy and Security Considerations in the Life Sciences Industry
Oct 19, 2017
Selecta Biosciences CEO Dr. Werner Cautreels talks about the company's innovative technology and how his entrepreneurial experiences in big pharma prepared him for the challenge of a new startup.
Oct 09, 2017
Pharmaceutical Executive
What is the true potential of real-world evidence studies and what are the right questions to ask in determining product performance in the marketplace?
Oct 06, 2017
TESARO president and COO Mary Lynne Hedley talks about responsible drug development and commercialization, and the practical dimension of putting patients first.
Oct 03, 2017
With the NASH pipeline filling up fast, Mariel Metcalfe looks at what pharma companies need to do to ensure their products do not end up as also-rans in this dynamic new market segment.
Oct 03, 2017
Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the Non-alcoholic Steatohepatitis market.
Sep 22, 2017
Healthcare companies are overwhelming physicians and hospitals with brand messaging overlap. Let’s use data science to fix that, says Kevin Troyanos.
native1_300x100
lorem ipsum